VF
ROSG

Virtu Financial’s Rosetta Genomics Ltd. ROSG Stock Holding History

Virtu Financial’s Portfolio ROSG Stock Details ROSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-76,846
Closed -$43K – 3087
2017
Q4 		$43K Sell
76,846
-4,533
-6% -$3.56K ﹤0.01% 2107
2017
Q3 		$85K Buy
+81,379
New +$144K ﹤0.01% 2115

Other funds holding ROSG

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HCM
Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return

Virtu Financial's ROSG Position: Q1 2018 in Review

Virtu Financial sold out of Rosetta Genomics Ltd. (ROSG) in Q1 2018, closing a stake of 76,846 shares — an estimated $43K sold.

Virtu Financial first reported a position in ROSG in Q3 2017 and held it in 2 quarters. The position peaked at $85K in Q3 2017. 8 funds tracked by Wall St. Rank hold ROSG as of Q1 2018.

  • Virtu Financial reported no remaining Rosetta Genomics Ltd. position as of Q1 2018 after selling out during the quarter.
  • Virtu Financial sold 76,846 Rosetta Genomics Ltd. shares in Q1 2018, an estimated $43K.
  • Virtu Financial first reported a position in Rosetta Genomics Ltd. in Q3 2017 and held it in 2 quarters.
  • Virtu Financial's Rosetta Genomics Ltd. position peaked at $85K in Q3 2017.
  • 8 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q1 2018.

Based on Virtu Financial's 13F filing for Q1 2018, filed 14 May 2018.